Literature DB >> 31219758

Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases.

Dong Hwan Kim, Sang Hyun Choi, So Yeon Kim, Min-Ju Kim, Seung Soo Lee, Jae Ho Byun.   

Abstract

Entities:  

Year:  2019        PMID： 31219758     DOI： 10.1148/radiol.2019194011

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  7 in total

Review 1.  Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI.

Authors:  Cathryn L Hui; Marcela Mautone
Journal:  Br J Radiol       Date:  2020-06-01       Impact factor: 3.039

2.  A New Diagnostic Criterion with Gadoxetic Acid-Enhanced MRI May Improve the Diagnostic Performance for Hepatocellular Carcinoma.

Authors:  Yi Wei; Zheng Ye; Yuan Yuan; Zixing Huang; Xiaocheng Wei; Tong Zhang; Shang Wan; Hehan Tang; Xiaopeng He; Bin Song
Journal:  Liver Cancer       Date:  2020-04-14       Impact factor: 11.740

3.  Can modified LI-RADS increase the sensitivity of LI-RADS v2018 for the diagnosis of 10-19 mm hepatocellular carcinoma on gadoxetic acid-enhanced MRI?

Authors:  Sidong Xie; Yao Zhang; Jingbiao Chen; Ting Jiang; Weimin Liu; Dailin Rong; Lin Sun; Linqi Zhang; Bingjun He; Jin Wang
Journal:  Abdom Radiol (NY)       Date:  2021-11-13

4.  Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria.

Authors:  Jae Hyon Park; Yong Eun Chung; Nieun Seo; Jin-Young Choi; Mi-Suk Park; Myeong-Jin Kim
Journal:  PLoS One       Date:  2020-11-13       Impact factor: 3.240

5.  Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort.

Authors:  Max Seidensticker; Ingo G Steffen; Irene Bargellini; Thomas Berg; Alberto Benito; Bernhard Gebauer; Roberto Iezzi; Christian Loewe; Musturay Karçaaltincaba; Maciej Pech; Christian Sengel; Otto van Delden; Vincent Vandecaveye; Christoph J Zech; Jens Ricke
Journal:  Curr Oncol       Date:  2022-01-27       Impact factor: 3.677

6.  Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?

Authors:  So Yeon Kim
Journal:  Clin Mol Hepatol       Date:  2020-06-15

7.  Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging.

Authors:  Christoph J Zech; Ahmed Ba-Ssalamah; Thomas Berg; Hersh Chandarana; Gar-Yang Chau; Luigi Grazioli; Myeong-Jin Kim; Jeong Min Lee; Elmar M Merkle; Takamichi Murakami; Jens Ricke; Claude B Sirlin; Bin Song; Bachir Taouli; Kengo Yoshimitsu; Dow-Mu Koh
Journal:  Eur Radiol       Date:  2019-08-05       Impact factor: 5.315
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.